Key result
Minimally invasive rapid deployment AVR reduced cross-clamp times and improved 1-year peak gradients compared to full sternotomy, but increased paravalvular leaks.
Why the study?
Does rapid deployment aortic valve replacement via minimally invasive surgery improve haemodynamic and clinical outcomes compared to conventional full sternotomy AVR in patients with aortic stenosis?
RCT (n=100)
randomized
Yes
Does rapid deployment aortic valve replacement via minimally invasive surgery improve haemodynamic and clinical outcomes compared to conventional full sternotomy AVR in patients with aortic stenosis?
Minimally invasive rapid deployment aortic valve replacement offers reduced cross-clamp times and improved haemodynamics at 1 year compared to conventional AVR, but at the cost of increased paravalvular leak rates.
Answers are grounded in this paper and cite their sources.
Requires weighing shorter clamp times against higher leak risk in AVR; extends RCT evidence on rapid deployment valves.
OBJECTIVES: Aortic valve replacement (AVR) via minimally invasive surgery (MIS) may provide clinical benefits in patients with aortic valve disease.A new class of bioprosthetic valves that enable rapid deployment AVR (RDAVR) may facilitate MIS.We here report the 1-year results of a randomized, multicentre trial comparing the outcomes for MIS-RDAVR with those for conventional AVR via full sternotomy (FS) with a commercially available stented aortic bioprosthesis.METHODS: A total of 100 patients with aortic stenosis were enrolled in a prospective, multicentre, randomized comparison trial (CADENCE-MIS).Key exclusion criteria included AVR requiring concomitant procedures, ejection fraction of <25% and recent myocardial infarction or stroke.Patients were randomized to undergo MIS-RDAVR via upper hemisternotomy (EDWARDS INTUITY) or AVR via FS with a commercially available stented valve.Procedural, early and late clinical outcomes were assessed for both groups.Haemodynamic performance was evaluated by an echocardiography CoreLaboratory.RESULTS: Technical success was achieved in 94% of MIS-RDAVR patients.MIS-RDAVR was associated with significantly reduced cross-clamp times compared with FS (41.3 ± 20.3 vs 54.0 ± 20.3 min, P < 0.001).Clinical and functional outcomes were similar at 30 days and 1 year postoperatively for both groups.While both groups received a similarly sized implanted valve (22.9 ± 2.1 mm MIS-RDAVR vs 23.0 ± 2.1 mm FS-AVR; P = 0.91), MIS-RDAVR patients had significantly lower peak gradients 1 year postoperatively (16.9 ± 5.3 vs 21.9 ± 8.6 mmHg; P = 0.033) and a trend towards lower mean gradients (9.1 ± 2.9 vs 11.5 ± 4.3 mmHg; P = 0.082).In addition, MIS-RDAVR patients had a significantly larger effective orifice area 1 year postoperatively (1.9 ± 0.5 vs 1.7 ± 0.4 cm 2 ; P = 0.047).Paravalvular leaks, however, were significantly more common in the MIS-RDAVR group (P = 0.027).CONCLUSIONS: MIS-RDAVR is associated with a significantly reduced cross-clamp time and better valvular haemodynamic function than FS-AVR.However, paravalvular leak rates are higher with MIS-RDAVR.
No takes yet. Share an insight, caveat, or question.
Borger et al. (2016) conducted an RCT in aortic stenosis (n=100). Minimally invasive rapid deployment aortic valve replacement (MIS-RDAVR) vs. Conventional aortic valve replacement via full sternotomy was evaluated on cross-clamp time (p=<0.001). Minimally invasive rapid deployment AVR reduced cross-clamp times and improved 1-year peak gradients compared to full sternotomy, but increased paravalvular leaks.
Synapse has enriched 10 related papers. Consider them for comparative context: